ResMed's GAAP net income for 6 months of fiscal 2022 was $405.364 million, up 13.3% from $357.886 million in the prior year. Revenue increased 15.9% to $1.799 billion from $1.552 billion a year earlier.
ResMed's GAAP net income for 6 months of fiscal 2022 was $405.364 million, up 13.3% from $357.886 million in the prior year. Revenue increased 15.9% to $1.799 billion from $1.552 billion a year earlier. 
investor.resmed.com
English (US) 